Keywords: uk, nice, backs, methylphenidate, adhd, hep, combination

UK's NICE backs methylphenidate for ADHD and hep C combination therapy

Article | 31 October 2000

Print This

The National Institute for Clinical Excellence, which provides guidanceto the National Health Service in England and Wales on medicines based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in